Fee-for-service activities provided by drug information centers

Therapeutic-interchange program for oral histamine H2-receptor antagonists.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998

Hyperkalemia and high-dose trimethoprim/sulfamethoxazole.

The Annals of pharmacotherapy·1995

Pharmaceutical services and inpatient drug costs in bone marrow transplantation.

American journal of hospital pharmacy·1994

The formulary decision-making process in a US academic medical centre.

PharmacoEconomics·1992

Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients.

The Annals of pharmacotherapy·1992

P & T Committee response to evolving technologies: preparing for the launch of high-tech, high-cost products. Roundtable discussion.

Hospital formulary·1992

Clozapine therapy for Parkinson's disease and other movement disorders.

American journal of hospital pharmacy·1994

Venlafaxine: a heterocyclic antidepressant.

American journal of hospital pharmacy·1994

Reassessing R&D outcomes of leading pharmaceutical companies.

Drug discovery today·2026

Linking the TVT Registry to Medicare Advantage and Fee-for-Service Claims: Feasibility, Accuracy, and Implications for Real-World Surveillance Infrastructure.

Circulation. Cardiovascular interventions·2026

Systemic regulation of the private healthcare sector is needed to ensure patient accessibility is not limited by out-of-pocket costs.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026

Disparities in Industry Payments Between Orthopaedic Surgery and General Surgery Residents.

JB & JS open access·2026

Zero-deforestation commitments in Indonesia's palm oil sector achieve high compliance but no additionality.

Proceedings of the National Academy of Sciences of the United States of America·2026

Gross Negligence in Bank Payments Law.

Oxford journal of legal studies·2026

Related Experiment Videos

Fee-for-service activities provided by drug information centers

Related Concept Videos

Therapeutic-interchange program for oral histamine H2-receptor antagonists.

Hyperkalemia and high-dose trimethoprim/sulfamethoxazole.

Pharmaceutical services and inpatient drug costs in bone marrow transplantation.

The formulary decision-making process in a US academic medical centre.

Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients.

P & T Committee response to evolving technologies: preparing for the launch of high-tech, high-cost products. Roundtable discussion.

Clozapine therapy for Parkinson's disease and other movement disorders.

Venlafaxine: a heterocyclic antidepressant.

Reassessing R&D outcomes of leading pharmaceutical companies.

Linking the TVT Registry to Medicare Advantage and Fee-for-Service Claims: Feasibility, Accuracy, and Implications for Real-World Surveillance Infrastructure.

Systemic regulation of the private healthcare sector is needed to ensure patient accessibility is not limited by out-of-pocket costs.

Disparities in Industry Payments Between Orthopaedic Surgery and General Surgery Residents.

Zero-deforestation commitments in Indonesia's palm oil sector achieve high compliance but no additionality.

Gross Negligence in Bank Payments Law.

Related Experiment Videos

Fee-for-service activities provided by drug information centers

Related Concept Videos

Related Articles